Position in BEAM
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$76,390,963
+$25,047,443 QoQ
Shares Held
2,225,844
+3.3% QoQ
Ownership
2.15%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#14
of 274 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 91%
Shared 6%
None 4%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,868 across 230 Biotechnology names. BEAM ranks #21 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in BEAM
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76,390,963 | 2,225,844 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $51,343,520 | 2,154,575 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $53,995,203 | 1,947,879 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $41,751,435 | 1,720,290 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $29,914,957 | 1,758,669 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $31,170,893 | 1,596,052 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $38,152,268 | 1,538,398 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $30,388,109 | 1,240,331 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $24,586,502 | 1,049,360 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $21,207,085 | 641,861 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $15,429,872 | 566,858 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $10,029,017 | 417,007 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9,088,107 | 284,626 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,522,958 | 180,371 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,866,260 | 124,425 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $684,825 | 14,375 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $701,773 | 18,129 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,064,175 | 18,572 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $849,654 | 10,662 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $902,032 | 10,367 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $705,459 | 5,481 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $440,139 | 5,499 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||